159 related articles for article (PubMed ID: 19820687)
21. Cdx2 transcription factor regulates claudin-3 and claudin-4 expression during intestinal differentiation of gastric carcinoma.
Satake S; Semba S; Matsuda Y; Usami Y; Chiba H; Sawada N; Kasuga M; Yokozaki H
Pathol Int; 2008 Mar; 58(3):156-63. PubMed ID: 18251778
[TBL] [Abstract][Full Text] [Related]
22. Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice.
Mutoh H; Sakurai S; Satoh K; Osawa H; Hakamata Y; Takeuchi T; Sugano K
Gut; 2004 Oct; 53(10):1416-23. PubMed ID: 15361487
[TBL] [Abstract][Full Text] [Related]
23. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas.
Almeida R; Silva E; Santos-Silva F; Silberg DG; Wang J; De Bolós C; David L
J Pathol; 2003 Jan; 199(1):36-40. PubMed ID: 12474224
[TBL] [Abstract][Full Text] [Related]
24. Down regulation of gastric and intestinal phenotypic expression in Epstein-Barr virus-associated stomach cancers.
Hirano N; Tsukamoto T; Mizoshita T; Koriyama C; Akiba S; Campos F; Carrasquilla G; Carrascal E; Cao X; Toyoda T; Ban H; Miki K; Tatematsu M
Histol Histopathol; 2007 Jun; 22(6):641-9. PubMed ID: 17357094
[TBL] [Abstract][Full Text] [Related]
25. Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus.
Makita K; Kitazawa R; Semba S; Fujiishi K; Nakagawa M; Haraguchi R; Kitazawa S
World J Gastroenterol; 2013 Jan; 19(4):536-41. PubMed ID: 23382633
[TBL] [Abstract][Full Text] [Related]
26. [Expression and significance of caudal type transcription factor-2 in gastric mucosa at different stages of gastric carcinogenesis].
Chen HX; Chen MH; Song X
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):247-9. PubMed ID: 16677504
[TBL] [Abstract][Full Text] [Related]
27. Low-grade gastric adenomas/dysplasias: phenotypic expression, DNA ploidy pattern, and LOH at microsatellites linked to the APC gene.
Tanaka A; Takemura-Tsukashita S; Kushima R; Sugihara H; Fujiyama Y; Hattori T
Pathol Res Pract; 2008; 204(1):1-9. PubMed ID: 17964080
[TBL] [Abstract][Full Text] [Related]
28. The relationship among PDX1, CDX2, and mucin profiles in gastric carcinomas; correlations with clinicopathologic parameters.
Oz Puyan F; Can N; Ozyilmaz F; Usta U; Sut N; Tastekin E; Altaner S
J Cancer Res Clin Oncol; 2011 Dec; 137(12):1749-62. PubMed ID: 21909647
[TBL] [Abstract][Full Text] [Related]
29. Gastric pit dysplasia in adjacent gastric mucosa in 414 gastric cancers: prevalence and characteristics.
Shin N; Jo HJ; Kim WK; Park WY; Lee JH; Shin DH; Choi KU; Kim JY; Lee CH; Sol MY; Jeon TY; Kim DW; Huh GY; Kim GH; Lauwers GY; Park DY
Am J Surg Pathol; 2011 Jul; 35(7):1021-9. PubMed ID: 21677540
[TBL] [Abstract][Full Text] [Related]
30. Expression of Cdx2 and claudin-2 in the multistage tissue of gastric carcinogenesis.
Xin S; Huixin C; Benchang S; Aiping B; Jinhui W; Xiaoyan L; Yu WB; Minhu C
Oncology; 2007; 73(5-6):357-65. PubMed ID: 18500171
[TBL] [Abstract][Full Text] [Related]
31. Sox2 expression is maintained while gastric phenotype is completely lost in Cdx2-induced intestinal metaplastic mucosa.
Mutoh H; Sashikawa M; Sugano K
Differentiation; 2011 Feb; 81(2):92-8. PubMed ID: 21036460
[TBL] [Abstract][Full Text] [Related]
32. Esophageal dysplasia and adenocarcinoma: a study with double immunostaining for intestinal and gastric markers.
Chlumská A; Mukenšnabl P; Waloschek T; Zámečník M
Cesk Patol; 2018; 54(2):81-85. PubMed ID: 30441967
[TBL] [Abstract][Full Text] [Related]
33. CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach.
Ko S; Chu KM; Luk JM; Wong BW; Yuen ST; Leung SY; Wong J
J Pathol; 2005 Apr; 205(5):615-22. PubMed ID: 15732140
[TBL] [Abstract][Full Text] [Related]
34. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
35. Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis.
Domori K; Nishikura K; Ajioka Y; Aoyagi Y
Gastric Cancer; 2014 Apr; 17(2):263-72. PubMed ID: 23828549
[TBL] [Abstract][Full Text] [Related]
36. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.
Mizoshita T; Tsukamoto T; Nakanishi H; Inada K; Ogasawara N; Joh T; Itoh M; Yamamura Y; Tatematsu M
J Cancer Res Clin Oncol; 2003 Dec; 129(12):727-34. PubMed ID: 14557879
[TBL] [Abstract][Full Text] [Related]
37. [Expression of intestine-specific transcription factor CDX2 in different subtypes of intestinal metaplasia and gastric carcinoma].
Liu GS; Gong J; Cheng P; Zhang J; Chang Y; Qiang L
Ai Zheng; 2006 Feb; 25(2):185-9. PubMed ID: 16480583
[TBL] [Abstract][Full Text] [Related]
38. Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.
Roessler K; Mönig SP; Schneider PM; Hanisch FG; Landsberg S; Thiele J; Hölscher AH; Dienes HP; Baldus SE
World J Gastroenterol; 2005 Jun; 11(21):3182-8. PubMed ID: 15929165
[TBL] [Abstract][Full Text] [Related]
39. Inactivation of NKX6.3 in the stomach leads to abnormal expression of CDX2 and SOX2 required for gastric-to-intestinal transdifferentiation.
Yoon JH; Choi SS; Kim O; Choi WS; Park YK; Nam SW; Lee JY; Park WS
Mod Pathol; 2016 Feb; 29(2):194-208. PubMed ID: 26743476
[TBL] [Abstract][Full Text] [Related]
40. Intestinal metaplasia of the stomach and esophagus: an immunohistochemical study of 60 cases including comparison with normal and inflamed intestinal mucosa.
Chlumská A; Mukenšnabl P; Mareček P; Zámečník M
Cesk Patol; 2014 Jul; 50(3):141-8. PubMed ID: 25186595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
